Purchases and Sales Made in Q3 2021 in Candel Therapeutics, Inc. (CADL)
This table provides information about the institutional ownership of Candel Therapeutics, Inc. (CADL) during Q3 2021. The information is specifically focused on institutions that hold shares of Candel Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2021
Q3 2021
|
Franklin Resources Inc
San Mateo, CA |
BUY
|
- |
1.13MNew |
$6.47M - $12.6M
|
1.13M
$9.98M
|
|
Nov 04, 2021
Q3 2021
|
Sands Capital Ventures, LLC
Arlington, VA |
BUY
|
- |
795KNew |
$4.57M - $8.92M
|
795K
$7.05M
|
|
Nov 12, 2021
Q3 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
214KNew |
$1.23M - $2.39M
|
214K
$1.89M
|
|
Nov 15, 2021
Q3 2021
|
Woodline Partners LP
San Francisco, CA |
BUY
|
- |
100KNew |
$575K - $1.12M
|
100K
$887K
|
|
Nov 15, 2021
Q3 2021
|
Caas Capital Management LP
New York, NY |
BUY
|
- |
50KNew |
$288K - $561K
|
50K
$443K
|
|
Nov 15, 2021
Q3 2021
|
State Street Corp
Boston, MA |
BUY
|
- |
26.6KNew |
$153K - $298K
|
26.6K
$236K
|
|
Nov 09, 2021
Q3 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
22.3KNew |
$128K - $250K
|
22.3K
$198K
|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
20.4KNew |
$117K - $229K
|
20.4K
$181K
|
|
Nov 12, 2021
Q3 2021
|
Sands Capital Ventures, LLC
Arlington, VA |
BUY
|
- |
16.4K+ 2.06% |
$94.1K - $183K
|
812K
$7.2M
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
3KNew |
$17.3K - $33.6K
|
3K
$26.6K
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1.05KNew |
$6.06K - $11.8K
|
1.05K
$9.35K
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|